ATE444744T1 - Komplementäre zusammensetzungen zur verringerung der blutzuckerspiegel und zur behandlung von diabetes - Google Patents

Komplementäre zusammensetzungen zur verringerung der blutzuckerspiegel und zur behandlung von diabetes

Info

Publication number
ATE444744T1
ATE444744T1 AT06749448T AT06749448T ATE444744T1 AT E444744 T1 ATE444744 T1 AT E444744T1 AT 06749448 T AT06749448 T AT 06749448T AT 06749448 T AT06749448 T AT 06749448T AT E444744 T1 ATE444744 T1 AT E444744T1
Authority
AT
Austria
Prior art keywords
composition
blood sugar
reducing blood
treating diabetes
sugar levels
Prior art date
Application number
AT06749448T
Other languages
English (en)
Inventor
Eric Hayes
Alexander Zolotoy
Original Assignee
Astrum Therapeutics Pty Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrum Therapeutics Pty Ltd filed Critical Astrum Therapeutics Pty Ltd
Application granted granted Critical
Publication of ATE444744T1 publication Critical patent/ATE444744T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/194—Carboxylic acids, e.g. valproic acid having two or more carboxyl groups, e.g. succinic, maleic or phthalic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/191—Carboxylic acids, e.g. valproic acid having two or more hydroxy groups, e.g. gluconic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/28—Compounds containing heavy metals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
    • A61K31/385—Heterocyclic compounds having sulfur as a ring hetero atom having two or more sulfur atoms in the same ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/555—Heterocyclic compounds containing heavy metals, e.g. hemin, hematin, melarsoprol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/736—Glucomannans or galactomannans, e.g. locust bean gum, guar gum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/14—Alkali metal chlorides; Alkaline earth metal chlorides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
    • A61K36/258—Panax (ginseng)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/54—Lauraceae (Laurel family), e.g. cinnamon or sassafras
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/888—Araceae (Arum family), e.g. caladium, calla lily or skunk cabbage
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Botany (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Inorganic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Diabetes (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AT06749448T 2005-04-07 2006-04-07 Komplementäre zusammensetzungen zur verringerung der blutzuckerspiegel und zur behandlung von diabetes ATE444744T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US66968205P 2005-04-07 2005-04-07
PCT/US2006/012903 WO2006110491A2 (en) 2005-04-07 2006-04-07 Complementary compositions to reduce blood glucose levels and treat diabetes

Publications (1)

Publication Number Publication Date
ATE444744T1 true ATE444744T1 (de) 2009-10-15

Family

ID=36999982

Family Applications (1)

Application Number Title Priority Date Filing Date
AT06749448T ATE444744T1 (de) 2005-04-07 2006-04-07 Komplementäre zusammensetzungen zur verringerung der blutzuckerspiegel und zur behandlung von diabetes

Country Status (6)

Country Link
US (1) US7687082B2 (de)
EP (1) EP1874285B1 (de)
AT (1) ATE444744T1 (de)
AU (1) AU2006235123A1 (de)
DE (1) DE602006009641D1 (de)
WO (1) WO2006110491A2 (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1996176B1 (de) * 2006-02-21 2010-05-19 Astrum Therapeutics Pty, Ltd. Zusammensetzungen zur verringerung des blutglukosespiegels und zur behandlung von diabetes
US8652550B2 (en) 2008-01-16 2014-02-18 Hydro One, Llc Health beverages comprising cinnamon extract and methods of making and using the same
CA2642184A1 (en) * 2008-10-28 2010-04-28 Goliath Oil And Gas Corporation Composition containing ginseng and cinnamon
US9918489B2 (en) 2008-12-17 2018-03-20 Mark Gorris Food-based supplement delivery system
US20100178413A1 (en) * 2008-12-17 2010-07-15 Mark Gorris Food-based Supplement Delivery System
ES2395529B1 (es) 2011-06-08 2014-04-11 Pri, S.A. Combinación sinérgica para el tratamiento de la diabetes mellitus tipo 2.
CN102526198A (zh) * 2012-03-14 2012-07-04 南昌大学 一种以肉桂和铬为添加剂的药品及保健品的制备方法
CN103436582B (zh) * 2013-07-10 2015-12-23 马杰坤 一种魔芋多肽提取物、制备方法及其用途
GB201319525D0 (en) 2013-11-05 2013-12-18 Optibiotix Health Ltd Composition

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH08127538A (ja) * 1994-10-31 1996-05-21 Masakiyo Takahashi 糖尿病治療薬
US5962030A (en) * 1997-03-07 1999-10-05 Akesis Pharmaceuticals, Inc. Dietary supplement and method of treatment for diabetic control
US6376549B1 (en) * 1998-09-17 2002-04-23 Akesis Pharmaceuticals, Inc. Metforimin-containing compositions for the treatment of diabetes
WO2000057721A2 (en) * 1999-03-26 2000-10-05 Akesis Pharmaceuticals, Inc. Edible solids for treatment of glucose metabolism disorders
US6562836B1 (en) * 1999-05-24 2003-05-13 Queen's University Of Kingston Methods and compounds for inhibiting amyloid deposits
US6207714B1 (en) * 1999-09-14 2001-03-27 Dallas L. Clouatre Methods and pharmaceutical preparations for improving glucose metabolism with (−)-hydroxycitric acid
US7326404B2 (en) * 2000-05-31 2008-02-05 Vuksan Holdings Inc. Konjac-mannan and ginseng compositions and methods and uses thereof
CA2310513A1 (en) * 2000-05-31 2001-11-30 Vladimir Vuksan Compositions and methods for reducing blood glucose
WO2002036202A2 (en) * 2000-11-02 2002-05-10 Nutrition 21, Inc. Methods and compositions for the improvement of insulin sensitivity, reduction of hyperglycemia, and reduction of hypercholesterolemia with chromium complexes and alpha lipoic acid
TWI329516B (en) * 2000-12-12 2010-09-01 Kaneka Corp Composition for preventing or ameliorating multiple risk factor syndromes and visceral fat-type obesity
US20020147153A1 (en) * 2001-02-14 2002-10-10 Functional Foods, Inc. Nutritional supplement to alleviate symptoms associated with reduced levels of serotonin
US6849613B2 (en) * 2001-08-29 2005-02-01 Kedar N. Prasad Multiple antioxidant micronutrients
WO2003077901A1 (en) * 2002-03-08 2003-09-25 Protemix Corporation Limited Preventing and/or treating cardiovascular disease and/or associated heart failure
US6787163B2 (en) * 2003-01-21 2004-09-07 Dennis H. Harris Therapeutic treatment for blood sugar regulation
CN1302712C (zh) * 2005-11-08 2007-03-07 南京中脉科技发展有限公司 一种减肥饼干及其制备方法

Also Published As

Publication number Publication date
EP1874285B1 (de) 2009-10-07
DE602006009641D1 (de) 2009-11-19
US20060251736A1 (en) 2006-11-09
WO2006110491B1 (en) 2007-05-31
AU2006235123A1 (en) 2006-10-19
EP1874285A2 (de) 2008-01-09
WO2006110491A3 (en) 2007-04-05
WO2006110491A2 (en) 2006-10-19
US7687082B2 (en) 2010-03-30

Similar Documents

Publication Publication Date Title
ATE444744T1 (de) Komplementäre zusammensetzungen zur verringerung der blutzuckerspiegel und zur behandlung von diabetes
Liu et al. Antidiabetic effect of Pycnogenol® French maritime pine bark extract in patients with diabetes type II
WO2007002836A3 (en) Methods and compositions for the prevention and treatment of kidney disease
DE602007006641D1 (de) Zusammensetzungen zur verringerung des blutglukosespiegels und zur behandlung von diabetes
EA200900940A1 (ru) Фармацевтическая композиция, содержащая пиразол-о-глюкозидное производное
WO2005009398A3 (en) Tetracyclic benzamide derivatives and methods of use thereof
ATE539748T1 (de) Glucokinaseaktivatoren
EA201000515A1 (ru) Активаторы глюкокиназы
WO2005113016A3 (en) Modulation of glucose-6-phosphatase translocase expression
EA201100266A1 (ru) Диокса-бицикло[3.2.1]октан-2,3,4-триольные производные
WO2007002572A3 (en) Nattokinase for reducing whole blood viscosity
MX2013004699A (es) Combinaciones farmaceuticas para el tratamiento de trastornos metabolicos.
NO20064584L (no) Tetrahydropyridoindolderivater
WO2008108957A3 (en) Piperidinyl-piperidine and piperazinyl-piperidine for use in the treatment of diabetes or pain
WO2007127273A3 (en) Methods and compositions for altering cell function
DE602005021770D1 (de) Indol-1-yl-essigsäurederivate
WO2005023083A3 (en) Compositions and methods for the treatment of severe acute respiratory syndrome (sars)
EA200501936A1 (ru) Производные пиридо[2,1-a]изохинолина в качестве ингибиторов dpp-iv
WO2008108958A8 (en) Benzimidazole derivatives and methods of use thereof
EA201200968A1 (ru) Применение транс-кломифена для предотвращения или лечения диабета 2 типа у мужчин
TW200616985A (en) Salicylthiazoles substituted by diphenylamine or diphenylamine derivatives, process for their preparation and their use
WO2009061453A8 (en) Solubilized thiazolopyridines
WO2008078176A9 (en) Methods, compounds, and compositions for treating metabolic disorders and diabetes
UA106209C2 (en) Choline cocrystal of 5-[(1z,2e)-2-methyl-3-phenylpropenylidene]-4-oxo-2-thioxo-3-thiazolidine acetic acid
EP1968561B8 (de) Behandlung von diabetischer nephropathie

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties